Document is current
Any future updates will be listed below
-
Authors
Schaffrath, Anja https://orcid.org/0000-0002-3084-3557
Schleyken, Sophia
Seger, Aline
Jergas, Hannah
Özdüzenciler, Pelin
Pils, Marlene
Blömeke, Lara https://orcid.org/0000-0002-8861-9224
Cousin, Anneliese
Willbold, Johannes
Bujnicki, Tuyen
Bannach, Oliver
Fink, Gereon R.
Willbold, Dieter https://orcid.org/0000-0002-0065-7366
Sommerauer, Michael https://orcid.org/0000-0001-5723-9766
Barbe, Michael T.
Tamgüney, Gültekin https://orcid.org/0000-0002-6933-5154
-
Funding
Funding for this research was provided by:
Parkinson’s Foundation (PF-IMP-2022)
Deutsche Forschungsgemeinschaft (431549029)
Else Kröner-Fresenius-Stiftung (2019_EKES.02)
Köln Fortune Programme, Faculty of Medicine, University of Cologne
- License Information
-
More Information
Article History
Received: 2 November 2022
Accepted: 16 January 2023
First Online: 2 February 2023
Competing interests
: D.W. and O.B. declare no competing non-financial interests but the following competing financial interests: D.W. and O.B. are shareholders of attyloid GmbH. A.S., S.S., A.S., H.J., P.Ö., M.P., L.B., A.C., J.W., T.B., G.R.R., M.S., M.T.B., and G.T. declare no competing interests.
